Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)
Mes dernières consult.
Most popular
Rapport
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Oslo Bors
10/13/2017 10/16/2017 10/17/2017 10/18/2017 10/19/2017 Date
32(c) 30.7(c) 30.5(c) 31.1(c) 30.1(c) Last
110 330 83 555 53 466 108 782 71 012 Volume
+1.59% -4.06% -0.65% +1.97% -3.22% Change
More quotes
Financials ( NOK)
Sales 2017 148 M
EBIT 2017 -46,5 M
Net income 2017 -36,8 M
Finance 2017 108 M
Yield 2017 -
Sales 2018 216 M
EBIT 2018 -7,52 M
Net income 2018 -1,92 M
Finance 2018 95,8 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 3,81x
EV / Sales2018 2,66x
Capitalization 670 M
More Financials
Company
Photocure ASA engages as a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment.It operates through Commercial Franchise and Development Portfolio segments.The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and... 
Sector
Pharmaceuticals
Calendar
11/15Earnings Release
More about the company
Surperformance© ratings of Photocure ASA
Trading Rating : Investor Rating :
More Ratings
Latest news on PHOTOCURE ASA
10/18 PHOTOCURE ASA : FDA grants priority review for Cysview® supplemental New Drug Ap..
09/12 PHOTOCURE : Financial calendar
08/23 PHOTOCURE ASA : Results for second quarter and first half year of 2017
08/21 PHOTOCURE : Pengana/HunterHall- reduction in holding- Photocure ASA
08/18PHOTOCURE ASA : half-yearly earnings release
08/18 PHOTOCURE ASA : Blue Light Cystoscopy with Hexvix® reduces recurrence rate at 3 ..
08/16 PHOTOCURE ASA : Presentation of the second quarter and first half year 2017 resu..
08/16 PHOTOCURE : files supplemental New Drug Application with FDA for Blue Light Cyst..
07/31 PHOTOCURE ASA : First European study to show that Blue Light Flexible Cystoscopy..
07/26 PHOTOCURE : Disclosure of shareholding
More news
Sector news : Pharmaceuticals - NEC
02:19pDJEuropean Corporate Roundup for Thursday
11:31aDJEuropean Corporate Roundup for Thursday
08:48aDJMERCK AND : Chenault Among Few Black CEOs -- WSJ
07:53aDJROCHE : 3Q Sales Increase on Strong Performance of Recently Launched Drugs
10/18DJMERCK AND : Amex Retirement Shines Light on Lack of Diversity in CEO Ranks
More sector news : Pharmaceuticals - NEC
Latest Tweets
08/23Photocure ASA 2017 Q2 - Results - Earnings Call Slides
1
08/16Photocure ASA: Presentation of the second quarter and first half year 2017 re.. 
05/26Photocure : Jeremy Bahr appointed Chief Business Officer  
05/24PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow  
05/24PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow  
More tweets
Qtime:22
News from SeekingAlpha
08/23 Photocure ASA 2017 Q2 - Results - Earnings Call Slides
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 35,0  NOK
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Jan Hendrik Egberts Chairman
Gry Stensrud VP-Technical Development & Operations
Erik Dahl Chief Financial Officer
Inger Ferner Heglund Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA-27.38%84
JOHNSON & JOHNSON22.11%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER10.31%213 372
MERCK AND COMPANY7.88%173 214